vania-janet/multiturn-rag-retrieval-data huggingface dataset:
COVID-19 Testing At VA | Veterans Affairs
To get reminders for when to contact your care team or a nurse advice line, you can use our Annie text messaging service.
Subscribe to the Annie text messaging service

If you have any signs of emergency, call 911 or get help right away. Signs of emergency include symptoms like trouble breathing or continued pain or pressure in your chest.
Get the latest COVID-19 symptom information on the CDC website

 If your lab test results are negative 
 

This means you didn’t have an active infection at the time of testing. It doesn’t mean you haven’t been infected since that time or won’t become infected in the future.
Continue to follow safe practices. These include practices like wearing a mask, physical distancing, and washing your hands often. 
Note: This test also won’t tell you if you were infected with the coronavirus in the past. That’s a different type of test called an antibody test.
Learn more about COVID-19 tests on the FDA website 

 Request a lab test by secure message

Tags

 All Veterans
 

Thank you for your feedback.

Related information

VA benefits

 Health care
 

Apply for VA health care, find out how to access services, and manage your health and benefits online.

Need more help?

Health benefits hotline: 

 877-222-VETS (8387)
 

My HealtheVet help desk: 
 

eBenefits technical support: 
 

MyVA411 main information line: 
 

Telecommunications Relay Services (using TTY) 

 TTY: 711
 

Last updated: October 13, 2023

Feedback
Post-COVID Conditions: Information for Healthcare Providers
Investigators from partner organizations evaluate the use of a distance-learning platform to support primary health care providers (HCP) who care for patients at increased risk of Long COVID. The program has attracted >100 nationally recognized faculty/mentors representing multiple medical specialties.The Long COVID and Fatiguing Illness Recovery Program fills a critical community need for health information and clinical support.
Long COVID ECHO – ASU
A free, biweekly healthcare provider education session sharing best practices and consultation for providers treating or interested in best practices for Long COVID.
Foundations in Post-COVID Conditions – CANVAS
Free online education course (8 CME/CEU credits) on current Long COVID research for health professionals and students. Free enrollment ends 6/1/2024.
Schmidt Initiative for Long COVID Global ECHO Webinar Series – Session on Long COVID and Fatigue & Exercise

Clinician Outreach and Communication Activity (COCA)

Webinar Thursday, June 15, 2023 – Evaluating and Supporting Patients with Long COVID in Returning to Work
Webinar Thursday, May 5, 2022 – Evaluating and Supporting Patients Presenting with Cognitive Symptoms Following COVID
Webinar September 30, 2021 – Evaluating and Supporting Patients Presenting With Fatigue Following COVID-19
Webinar June 17, 2021 – Evaluating and Caring for Patients with Post-COVID Conditions

Other Tools and Resources

Find COVID-19 guidance for your community
Services and Supports for Longer-Term Impacts of COVID-19
The Accountable Health Communities Health-Related Social Needs Screening Tool 
Tools for providing trauma-informed care
Tools for cross-cultural communication
AAPM&R Long COVID (PASC) resources 
AAFP Social Determinants of Health resources

Top of PageReferences

Show All

Nalbandian A, Sehgal K, Gupta A, Madhavan MV, et al. Post-acute COVID-19 syndrome. Nat Med. 2021 Apr;27(4):601-615. doi:10.1038/s41591-021-01283-z
Policy Brief 39 – In the Wake of the Pandemic Preparing for Long COVID.
COVID-19 Testing At VA | Veterans Affairs
For COVID-19, a close contact is anyone who was less than 6 feet away from you for a combined total of 15 minutes or more over a 24-hour period. 
Monitor your symptoms. If your symptoms get worse, contact your provider or nearest VA health facility. To get reminders for when to contact your care team or a nurse advice line, you can use our Annie text messaging service.
Subscribe to the Annie text messaging service

If you have any signs of emergency, call 911 or get help right away. Signs of emergency include symptoms like trouble breathing or continued pain or pressure in your chest.
Get the latest COVID-19 symptom information on the CDC website

Note: If your self-test results are positive, you don’t need to schedule a lab test.

 If your results are negative 
 

Consider taking another at-home test in 2 or 3 days.
Monitor your symptoms. If you have symptoms, you could still have COVID-19 or another illness like the flu. Contact your VA health care team for advice and to schedule a lab test at VA.
Send a secure message to tell your VA provider about your symptoms
Find your provider’s or facility’s phone number

If you have any signs of emergency, call 911 or get help right away. Signs of emergency include symptoms like trouble breathing or continued pain or pressure in your chest.
Get the latest COVID-19 symptom information on the CDC website

 If your results are invalid 
 

Follow the test instructions for next steps.

Schedule a COVID-19 lab test at VA

Who can get a lab test at VA
We offer diagnostic lab-based tests (PCR tests) for Veterans who are enrolled in VA health care. We follow testing guidelines from the Centers for Disease Control and Prevention (CDC).
At this time, we don’t charge copays for COVID-19 tests. But if you get the test during an appointment with a health care provider, you may have a copay for the appointment.

How to schedule your lab test
The fastest way to get a test is to request an appointment. You can request an appointment in any of these 3 ways:
How to Protect Yourself and Others | CDC
When you are sick:

Use precautions to prevent spread, including staying home and away from others (including people you live with who are not sick) if you have respiratory symptoms.

Learn when you can go back to your normal activities.

Seek health care promptly for testing and/or treatment if you have risk factors for severe illness. Treatment may help lower your risk of severe illness, but it needs to be started within a few days of when your symptoms begin.

Additional Prevention Strategies
In addition, there are other prevention strategies that you can choose to further protect yourself and others.

Wearing a mask and putting distance between yourself and others can help lower the risk of COVID-19 transmission.
Testing for COVID-19 can help you decide what to do next, like getting treatment to reduce your risk of severe illness and taking steps to lower your chances of spreading COVID-19 to others.

Key Times for Prevention
Using these prevention strategies can be especially helpful when:

Respiratory viruses, such as COVID-19, flu, and RSV, are causing a lot of illness in your community
You or those around you have risk factors for severe illness
You or those around you were recently exposed to a respiratory virus, are sick, or are recovering

Check Your CommunityFind out if respiratory viruses are causing a lot of illness in your community. Data updated weekly.
Check the latest data
Get the Latest on COVID-19, Flu, and RSVLearn more about all three of these respiratory viruses, who is most at risk, and how they are affecting your state right now. You can use some of the same strategies to protect yourself from all three viruses.
Get the Latest on COVID-19, Flu, and RSV

Related Pages
COVID-19 Testing
COVID-19 Vaccines
COVID-19 Treatments and Medications
Preventing Respiratory Viruses
Protect Yourself from COVID-19, Flu, and RSV

Additional Resources
Respirators and Masks
Improving Ventilation in Your Home
Improving Ventilation In Buildings

Archived ContentSearch for and find historical COVID-19 pages and files. Please note the content on these pages and files is no longer being updated and may be out of date.
People with Certain Medical Conditions | CDC
If you have symptoms consistent with COVID-19 and you are aged 50 years or older OR are at high risk of getting very sick, you may be eligible for treatment. Contact your healthcare provider and start treatment within the first 5-7 days after you first develop symptoms. You can also visit a Test to Treat location. Treatment can reduce your risk of hospitalization by more than 50% and also reduces the risk of death.
Staying up to date with COVID-19 vaccines and following preventive measures for COVID-19 are important. This is especially important if you are older or have severe health conditions or more than one health condition, including those on the list below.
Approved and authorized COVID-19 vaccines are safe and effective.
Some people who are immunocompromised, or people with weakened immune systems, may get additional doses of COVID-19 vaccine.

On this Page

OverviewMedical ConditionsAdditional Information on Children and Teens 

Overview
Based on the current evidence, a person with any of the conditions listed below is more likely to get very sick from COVID-19. This means that a person with one or more of these conditions who gets very sick from COVID-19 (has severe illness from COVID-19) is more likely to:

Be hospitalized
Need intensive care
Require a ventilator to help them breathe
Die

In addition:

Older adults are at highest risk of getting very sick from COVID-19. More than 81% of COVID-19 deaths occur in people over age 65. The number of deaths among people over age 65 is 97 times higher than the number of deaths among people ages 18-29 years.
A person’s risk of severe illness from COVID-19 increases as the number of underlying medical conditions they have increases.
Some people are at increased risk of getting very sick or dying from COVID-19 because of where they live or work, or because they can’t get health care. This includes many people from racial and ethnic minority groups and people with disabilities.

Studies have shown people from racial and ethnic minority groups are also dying from COVID-19 at younger ages.
Post-COVID Conditions: Information for Healthcare Providers
This category is heterogeneous, as it can include patients who have clinically important but poorly understood symptoms (e.g., difficulty thinking or concentrating, post-exertional malaise) that can be persistent or intermittent after initial acute infection with SARS-CoV-2.

Commonly reported symptoms include:

Dyspnea or increased respiratory effort
Fatigue
Post-exertional malaise* and/or poor endurance
Cognitive impairment or "brain fog"
Cough
Chest pain
Headache
Palpitations and tachycardia
Arthralgia
Myalgia
Paresthesia
Abdominal pain
Diarrhea
Insomnia and other sleep difficulties
Fever
Lightheadedness
Impaired daily function and mobility
Pain
Rash (e.g., urticaria)
Mood changes
Anosmia or dysgeusia
Menstrual cycle irregularities
Erectile dysfunction

* Post-exertional malaise (PEM) is the worsening of symptoms following even minor physical or mental exertion, with symptoms typically worsening 12 to 48 hours after activity and lasting for days or even weeks.

Prevalence
The prevalence of Post-COVID Conditions has been challenging to estimate, with estimates ranging widely (5–30%). Reasons for these wide-ranging estimates include:

differing symptoms or conditions investigated
the temporal criteria used (weeks up to many months following SARS-CoV-2 infection)
the study settings included (outpatient vs. inpatient)
Severity of acute COVID-19 illness
Differing patient populations (e.g., children vs. adults)
how symptoms and conditions are assessed (e.g., self-report vs. electronic health record database)

CDC posts data on Post-COVID Conditions and provides analyses, the most recent of which can be found on the U.S. Census Bureau’s Household Pulse Survey.
Possible causes
It can be difficult to distinguish symptoms caused by Post-COVID Conditions from symptoms that occur for other reasons. Alternative reasons for health problems need to be considered, such as other diagnoses or acute respiratory illness including SARS-CoV-2 reinfection.
Post-COVID Conditions: Information for Healthcare Providers
The World Health Organization (WHO) provided an ICD-10 code for Post-COVID Condition that was incorporated into the International Classification of Diseases, Tenth Edition Clinical Modification (ICD-10-CM) as of October 1, 2021:

U09.9 Post COVID-19 Condition, unspecified– to allow the establishment of a link with COVID-19; not to be used in cases that still are presenting with acute COVID-19.

The code should be used for patients with a history of probable or confirmed SARS CoV-2 infection who are identified with a Post-COVID Condition. In addition, assign codes for specific conditions and symptoms identified. ICD-10-CM coding guidance can be found at 2022 ICD-10-CM Guidelines [583 KB, 115 pages], pages 30-31 (Section I.C.1.g.1.m).
Top of PageResearch on Post-COVID Conditions
Medical and research communities are still learning about post-acute COVID-19 symptoms and clinical findings. Scientific knowledge is still limited, including what causes symptoms and how often they occur.
Researchers are actively studying the prevalence, mechanism, duration, and severity of symptoms following acute SARS-CoV-2 infection, as well as risk factors associated with Post-COVID Conditions. Whereas older patients and those with underlying health conditions might have an increased risk for severe disease, young people, including those who were physically fit before SARS-CoV-2 infection, have also reported symptoms lasting several months after acute illness. Current U.S. government Long COVID research and plans for accelerating research and innovation in Long COVID are summarized in the National Research Action Plan on Long COVID.
Clinics for Post-COVID Conditions have been established at medical centers across the United States, bringing together multidisciplinary teams to provide a comprehensive and coordinated treatment approach to COVID-19 aftercare.
CDC continues to actively investigate the full spectrum of COVID-19 illness, from the acute phase to long-term effects and conditions.
Post-COVID Conditions: Information for Healthcare Providers
how symptoms and conditions are assessed (e.g., self-report vs. electronic health record database)

CDC posts data on Post-COVID Conditions and provides analyses, the most recent of which can be found on the U.S. Census Bureau’s Household Pulse Survey.
Possible causes
It can be difficult to distinguish symptoms caused by Post-COVID Conditions from symptoms that occur for other reasons. Alternative reasons for health problems need to be considered, such as other diagnoses or acute respiratory illness including SARS-CoV-2 reinfection.
Post-COVID Conditions are heterogeneous and may be attributable to different underlying pathophysiologic processes. Researchers are working to characterize and differentiate the multiple possible etiologies, such as

organ damage resulting from acute phase infection
complications from a dysregulated inflammatory state
microvascular dysfunction
ongoing viral activity associated with an intra-host viral reservoir
autoimmunity
inadequate antibody response
other potential causes

Multiorgan system effects of acute COVID-19 and PCC
Acute SARS-CoV-2 infection and PCC have been documented to have the following effects:

cardiovascular
pulmonary
renal
psychologic
neurologic / cognitive
gastrointestinal
immunologic
endocrine
reproductive
genitourinary
dermatologic

A wide variety of health effects can persist after the acute COVID-19 illness has resolved (e.g., pulmonary fibrosis, myocarditis). Patients who experienced multisystem inflammatory syndrome (MIS) during or after COVID-19 illness may be at higher risk for on-going multiorgan system effects and Post-COVID Conditions. It is unknown how long multiorgan system effects might last and whether the effects could lead to chronic health conditions.
Patients who experienced multisystem inflammatory syndrome (MIS) during or after COVID-19 illness may be at higher risk for on-going multiorgan system effects and Post-COVID Conditions. It is unknown how long multiorgan system effects might last and whether the effects could lead to chronic health conditions.
Post-COVID Conditions: Information for Healthcare Providers
Buonsenso D, Munblit D, De Rose C, et al. Preliminary evidence on long COVID in children. Acta Paediatr. 2021 Apr 9. doi:10.1111/apa.15870
Say D, Crawford N, McNab S, et al. Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. Lancet Child Adolesc Health. 2021 Apr 20. doi:10.1016/S2352-4642(21)00124-3
Osmanov I, Spiridonova E, Bobkova P, et al. Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. medRxiv. 2021 Apr 26. doi:10.1101/2021.04.26.21256110
Assaf G, Davis H, McCorkell L, et al. What does COVID-19 recovery actually look like? An analysis of the prolonged COVID-19 symptoms survey by Patient-Led Research Team. Patient Led Research for COVID-19, 2020.
Lam MH, Wing YK, Yu MW, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009 Dec 14;169(22):2142-7. doi:10.1001/archinternmed.2009.384
Lee SH, Shin HS, Park HY, et al. Depression as a Mediator of Chronic Fatigue and Post-Traumatic Stress Symptoms in Middle East Respiratory Syndrome Survivors. Psychiatry Investig. 2019 Jan;16(1):59-64. doi:10.30773/pi.2018.10.22.3.
Lambert N, Survivor Corps, El-Azab SA, et al. COVID-19 Survivors’ Reports of the Timing, Duration, and Health Impacts of Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection.
Frequently Asked Questions | Department of Health
The CDC recommends that you get vaccinated even if you have already had COVID-19, because you can be infected more than once. While you may have some short-term antibody protection after recovering from COVID-19, we don’t know how long this protection will last. Vaccination is the best protection, and it is safe. People who get COVID-19 may have serious illnesses, and some have debilitating symptoms that persist for months.  

 Development
 
 
 

What is in the COVID-19 vaccines?The ingredients in Pfizer’s COVID-19 vaccine are listed on page 2 here.The ingredients in Moderna’s COVID-19 vaccine are listed on page 2 here.Did the clinical trials include people with comorbidities including diabetes or hypertension?Yes. Clinical trials for both vaccines included participants identified as having at least one condition that put them at increased risk of severe complications of COVID-19 including:Chronic lung disease (e.g., emphysema and chronic bronchitis, idiopathic pulmonary fibrosis, and cystic fibrosis) or moderate to severe asthmaSignificant cardiac disease (e.g., heart failure, coronary artery disease, congenital heart disease, cardiomyopathies, and pulmonary hypertension)Obesity (body mass index ≥ 30 kg/m2)Diabetes (Type 1, Type 2 or gestational)Liver diseaseHuman Immunodeficiency Virus (HIV) infection (not included in the efficacy evaluation)Do COVID-19 vaccines contain animal-based ingredients? No. The Moderna, Pfizer/BioNTech and Johnson & Johnson/Janssen COVID-19 vaccines contain no human or animal products, preservatives or adjuvants and utilize no ingredients of human or animal origin.

 Availability
 
 
 

When should I get the vaccine? COVID-19 vaccines are updated periodically to better protect against new strains of the virus. For more information on the most up- to- date vaccine formulation and vaccination schedule, visit the CDC website.I'm homebound. How can I get the vaccine?COVID vaccines are widely available at pharmacies, local health departments, clinics, Federally Qualified Health Centers and health care provider offices.
Post-COVID Conditions: Information for Healthcare Providers
Accessed at: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/1april2021
Chevinsky JR, Tao G, Lavery AM, et al. Late conditions diagnosed 1-4 months following an initial COVID-19 encounter: a matched cohort study using inpatient and outpatient administrative data – United States, March 1-June 30, 2020. Clin Infect Dis. 2021 Apr 28. doi: 10.1093/cid/ciab338
Hernandez-Romieu AC, Leung S, Mbanya A, et al. Health Care Utilization and Clinical Characteristics of Nonhospitalized Adults in an Integrated Health Care System 28-180 Days After COVID-19 Diagnosis – Georgia, May 2020-March 2021. MMWR Morb Mortal Wkly Rep. 2021 Apr 30;70(17):644-650. doi: 10.15585/mmwr.mm7017e3
Lund LC, Hallas J, Nielsen H, Koch A, Mogensen SH, Brun NC, Christiansen CF, Thomsen RW, Pottegård A. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect Dis. 2021 May 10. doi:10.1016/S1473-3099(21)00211-5
Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021 Jan 16;397(10270):220-232. doi:10.1016/S0140-6736(20)32656-8
Pavli A, Theodoridou M, Maltezou HC. Post-COVID syndrome: Incidence, clinical spectrum, and challenges for primary healthcare professionals. Arch Med Res. 2021 May 4.
Antibody (Serology) Testing for COVID-19: Information for Patients and Consumers | FDA
Face Masks, Barrier Face Coverings, Surgical Masks, and Respirators for COVID-19
Adverse Event Reporting for Medical Devices Under Emergency Use Authorization (EUA)
Contacts for Medical Devices Related to COVID-19

 

Footer Links

FDA Archive
About FDA
Accessibility

Visitor Information 
Website Policies / Privacy
No FEAR Act
Vulnerability Disclosure Policy

FOIA
HHS.gov
USA.gov

Contact FDA

Follow FDA on Facebook

Follow FDA on X

Follow FDA on Instagram

Follow FDA on LinkedIn

View FDA videos on YouTube

Subscribe to FDA RSS feeds

FDA Homepage

 
Contact Number
 1-888-INFO-FDA (1-888-463-6332)
 

Back to Top
معلومات لمقدمي الخدمات | دائرة الصحة
الاتاحةأنشأت HHS مصدرين لمساعدة مقدمي الخدمات: A COVID-19 Therapstics Locator والذي يمكن استخدامه لايجاد أماكن باستخدام Paxlovir أو Molnupiradir المتاح. A Medication Locator والتي يمكن استخدامها لايجاد Test to Tالمعالجة الأماكن والصيدليات لملء وصفات COVID-19. إذا كنت داخل مدينة نيويورك، يرجى الرجوع إلى: COVID-19 : معلومات علاجية للمرضى الخارجيين لمقدمي الخدمات-الصحة في اتفاقية نيويورك سيحتاج المرضى إلى وصفة طبية لباكسلوفيد ومولنوبيرافير (Lagevrio). جهة الاتصالبرجاء الاتصال بفريق COVID-19 Therapeutics في [ محمي بالبريد الالكتروني ] كان لديك أي أسئلة و / أو اهتمامات. 

 المضادات الحيوية المضادة للفيروسات (mAb)
Post-COVID Conditions: Information for Healthcare Providers
doi:10.3390/ijerph18084350
Parkin A, Davison J, Tarrant R, et al. A Multidisciplinary NHS COVID-19 Service to Manage Post-COVID-19 Syndrome in the Community. J Prim Care Community Health. 2021 Jan-Dec;12:21501327211010994. doi:10.1177/21501327211010994
Brigham E, O’Toole J, Kim SY, et al. The Johns Hopkins Post-Acute COVID-19 Team (PACT): A Multidisciplinary, Collaborative, Ambulatory Framework Supporting COVID-19 Survivors. Am J Med. 2021 Apr;134(4):462-467.e1. doi:10.1016/j.amjmed.2020.12.009
Santhosh L, Block B, Kim SY, Raju S, Shah RJ, Thakur N, Brigham EP, Parker AM. How I Do It: Rapid Design and Implementation of Post-COVID-19 Clinics. Chest. 2021 Mar 31. doi:10.1016/j.chest.2021.03.044
O’Brien H, Tracey MJ, Ottewill C, et al. An integrated multidisciplinary model of COVID-19 recovery care. Ir J Med Sci. 2021 May;190(2):461-468. doi:10.1007/s11845-020-02354-9
Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis. Res Sq. 2021 Mar 1. doi:10.2139/ssrn.3769978
Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of Post-acute sequalae of COVID-19. Nature. 2021 Apr 22.